A61K 47/00
Medicinal preparations characterised by the non-active ingredients used
Official title: Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A61K47/00 (Medicinal preparations characterised by the non-active ingredients used) appears on 51,529 US grants and 88,318 published applications in this corpus.
Search patents in A61K- Granted patents
- 51,529
- Published applications
- 88,318
- Assignees
- 20,705
- Inventors
- 116,431
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 62 | 0 |
| 1977 | 68 | 0 |
| 1978 | 71 | 0 |
| 1979 | 49 | 0 |
| 1980 | 58 | 0 |
| 1981 | 61 | 0 |
| 1982 | 79 | 0 |
| 1983 | 92 | 0 |
| 1984 | 116 | 0 |
| 1985 | 100 | 0 |
| 1986 | 109 | 0 |
| 1987 | 145 | 0 |
| 1988 | 161 | 0 |
| 1989 | 260 | 0 |
| 1990 | 245 | 0 |
| 1991 | 279 | 0 |
| 1992 | 336 | 0 |
| 1993 | 343 | 0 |
| 1994 | 285 | 0 |
| 1995 | 346 | 0 |
| 1996 | 442 | 0 |
| 1997 | 637 | 0 |
| 1998 | 755 | 0 |
| 1999 | 706 | 0 |
| 2000 | 608 | 0 |
| 2001 | 675 | 255 |
| 2002 | 715 | 1036 |
| 2003 | 656 | 1642 |
| 2004 | 544 | 1719 |
| 2005 | 463 | 1757 |
| 2006 | 687 | 1718 |
| 2007 | 554 | 1663 |
| 2008 | 526 | 1809 |
| 2009 | 623 | 2095 |
| 2010 | 917 | 2461 |
| 2011 | 969 | 2453 |
| 2012 | 1203 | 2527 |
| 2013 | 1632 | 3053 |
| 2014 | 2126 | 3890 |
| 2015 | 2276 | 4206 |
| 2016 | 2477 | 4436 |
| 2017 | 2727 | 4565 |
| 2018 | 2779 | 4620 |
| 2019 | 2901 | 5116 |
| 2020 | 3135 | 5453 |
| 2021 | 3111 | 5714 |
| 2022 | 2894 | 5679 |
| 2023 | 2745 | 5666 |
| 2024 | 2870 | 5737 |
| 2025 | 2955 | 5064 |
| 2026 | 1956 | 3984 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- A61K 47/50The non-active ingredient being chemically bound to the active ingredient25,001
- A61K 47/06Organic compounds19,718
- A61K 47/30Macromolecular organic or inorganic compounds13,642
- A61K 47/02Inorganic compounds5,619
- A61K 47/44Oils, fats or waxes according to two or more groups of a61k47/02-a61k47/422,744
- A61K 47/46Ingredients of undetermined constitution or reaction products thereof899
Recent patents
- Compositions and methods for laser lithotripsy using nanoparticle fine-tuned NIR absorption6 Oct 2026US 12,751,766 B2Duke University
- Hydrogels as oral delivery dosage forms, methods of making and using same6 Oct 2026US 12,751,917 B2VeraMorph LLC
- Ketamine formulation6 Oct 2026US 12,751,918 B2Fresenius Kabi USA, LLC
- Liposomal enhanced intra-peritoneal chemotherapy6 Oct 2026US 12,751,919 B2
- Medication that protects the intestinal microbiota and their preparation methods and applications6 Oct 2026US 12,751,921 B2University of Science and Technology of China
- Esketamine formulations and methods for preparation and storage8 Oct 2026US 2026/0306360 A1Janssen Pharmaceutica NV
- Cosmetic composition comprising an endolysin and an organic filler8 Oct 2026US 2026/0306385 A1L'oreal
- Hyaluronic acid hydrogels with agent to enhance resorption8 Oct 2026US 2026/0306398 A1Boston Scientific Scimed, Inc.
- A consumable gel for health ingredients8 Oct 2026US 2026/0306399 A1Gelteq Limited
- Formulation for an effective oral administration of ciclopirox with no adversal gastrointestinal toxicity8 Oct 2026US 2026/0306400 A1AsociacióN Centro De InvestigacióN Cooperativa En Biociencias-Cic Biogune
Most cited
By later US patents
- Non-immunogenic polypeptides2,007US 4,179,337 A1979
- Uncharged morpholino-based polymers having achiral intersubunit linkages1,700US 5,034,506 AAnti-Gene Development Group · 1991
- Polyhydroxyalkanoate compositions having controlled degradation rates1,516US 6,867,248 B1Metabolix, Inc. · 2005
- Medical scanning and treatment system and method1,502US 5,464,013 A1995
- Temperature-controlled active agent dispenser1,474US 4,830,855 ALandec Labs, Inc. · 1989